Role of prion protein oligomers in the pathogenesis of transmissible spongiform encephalopathies

Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases

Volumn 9789400727748, Issue , 2012, Pages 319-335

  Morales, Rodrigo ^a,b   Duran Aniotz, Claudia A ^a,b   Soto, Claudio ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

Misfolded oligomers; Neurodegeneration; Prions; Protein misfolding; Seeding

Indexed keywords

EID: 84876296932     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-2774-8_10     Document Type: Chapter

References (100)

1. Aguzzi A (2009) Cell biology: beyond the prion principle. Nature 459:924-925
2. Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3:11-40
3. Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301-307
4. Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson CM, Stefani M (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 279: 31374-31382
5. Bukau B, Weissman J, Horwich A (2006) Molecular chaperones and protein quality control. Cell 125:443-451
6. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267-298
7. Caughey B, Baron GS, Chesebro B, Jeffrey M (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78:177-204
8. Cheon M, Favrin G, Chang I, Dobson CM, Vendruscolo M (2008) Calculation of the free energy barriers in the oligomerization of A b peptide fragments. Front Biosci 13:5614-5622
9. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435-1439
10. Chiesa R, Piccardo P, Quaglio E, Drisaldi B, Si-Hoe SL, Takao M, Ghetti B, Harris DA (2003) Molecular distinction between pathogenic and infectious properties of the prion protein. J Virol 77:7611-7622
11. Chiesa R, Piccardo P, Biasini E, Ghetti B, Harris DA (2008) Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. J Neurosci 28:13258-13267
12. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL (2003) Self-assembly of A b 1-42 into globular neurotoxins. Biochemistry 42:12749-12760
13. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2004) Natural oligomers of the amyloid-b protein specifically disrupt cognitive function. Nat Neurosci 8:79-84
14. Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519-550
15. Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL (1990) Prion dementia without characteristic pathology. Lancet 336:7-9
16. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, Wadsworth JD (2008) Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 416:297-305
17. Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M (2008) Association between deposition of b-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis 5:347-354
18. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294-17300
19. Diaz-Espinoza R, Soto C (2010) Generation of prions in vitro and the protein-only hypothesis. Prion 4:53-59
20. Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M (2010) Peripherally applied A b-containing inoculates induce cerebral b-amyloidosis. Science 330:980-982
21. Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T (2001) Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathol (Berl) 101:49-56
22. Fink AL (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3:R9-R23
23. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362:543-546
24. Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11:155-159
25. Ganowiak K, Hultman P, Engstrom U, Gustavsson A, Westermark P (1994) Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun 199:306-312
26. Glabe CC (2005) Amyloid accumulation and pathogenesis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar A b. Subcell Biochem 38:167-177
27. Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27:570-575
28. Gotz J, Streffer JR, David D, Schild A, Hoerndli F, Pennanen L, Kurosinski P, Chen F (2004) Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry 9:664-683
29. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid b-peptide. Nat Rev Mol Cell Biol 8:101-112
30. Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 96: 116-122
31. Harper JD, Wong SS, Lieber CM, Lansbury PT Jr (1999) Assembly of A b amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38:8972-8980
32. Harris DA, True HL (2006) New insights into prion structure and toxicity. Neuron 50:353-357
33. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ (1999) Protofibrillar intermediates of amyloid b-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884
34. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827-834
35. Hetz CA, Soto C (2006) Stressing out the ER: A role of the unfolded protein response in prion-related disorders. Curr Mol Med 6:37-43
36. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C (2003) Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 22:5435-5445
37. Hill AF, Collinge J (2003) Subclinical prion infection in humans and animals. Br Med Bull 66:161-170
38. Hsiao K, Prusiner SB (1990) Inherited human prion diseases. Neurology 40:1820-1827
39. Jackson GS, Hosszu LL, Power A, Hill AF, Kenney J, Saibil H, Craven CJ, Waltho JP, Clarke AR, Collinge J (1999) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283:1935-1937
40. Jarrett JT, Lansbury PT Jr (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058
41. Jiang X, Smith CS, Petrassi HM, Hammarstrom P, White JT, Sacchettini JC, Kelly JW (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40:11442-11452
42. Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P, Westermark P (1998) Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 95:2558-2563
43. Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC (2000) Evidence for seeding of b-amyloid by intracerebral infusion of Alzheimer brain extracts in b-amyloid precursor protein-transgenic mice. J Neurosci 20:3606-3611
44. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489
45. Kazlauskaite J, Young A, Gardner CE, Macpherson JV, Venien-Bryan C, Pinheiro TJ (2005) An unusual soluble b-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells. Biochem Biophys Res Commun 328:292-305
46. Kisilevsky R, Boudreau L (1983) Kinetics of amyloid deposition. I. The effects of amyloidenhancing factor and splenectomy. Lab Invest 48:53-59
47. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506
48. Krebs MR, Morozova-Roche LA, Daniel K, Robinson CV, Dobson CM (2004) Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci 13:1933-1938
49. Lashuel HA, Lansbury PT Jr (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 39:167-201
50. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418:291
51. Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, Fournier JG, Hauw JJ, Rossier J, Dormont D (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402-405
52. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-b oligomers. Nature 457:1128-1132
53. Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, Davisson MT, Sundberg JP, Schimmel P, Ackerman SL (2006) Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 443:50-55
54. Leuba G, Saini K, Savioz A, Charnay Y (2000) Early-onset familial Alzheimer disease with coexisting b-amyloid and prion pathology. JAMA 283:1689-1691
55. Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative diseases. Cell Death Differ 13:385-392
56. Luheshi LM, Crowther DC, Dobson CM (2008) Protein misfolding and disease: from the test tube to the organism. Curr Opin Chem Biol 12:25-31
57. Ma J, Wollmann R, Lindquist S (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-1785
58. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV (2010) Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119:177-187
59. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, Serban A, Prusiner SB (1991) Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65:1340-1351
60. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL et al (2006) Exogenous induction of cerebral b-amyloidogenesis is governed by agent and host. Science 313:1781-1784
61. Miyazono M, Kitamoto T, Iwaki T, Tateishi J (1992) Colocalization of prion protein and b protein in the same amyloid plaques in patients with Gerstmann-Straüssler syndrome. Acta Neuropathol (Berl) 83:333-339
62. Modler AJ, Gast K, Lutsch G, Damaschun G (2003) Assembly of amyloid protofibrils via critical oligomers-a novel pathway of amyloid formation. J Mol Biol 325:135-148
63. Morales R, Hetz C, Soto C (2005) Signaling pathways controlling prion neurotoxicity: role of endoplasmic reticulum stress-mediated apoptosis. In: Brown DR (ed) Neurodegeneration and prion disease. Springer, New York, pp 319-344
64. Morales R, Chen B, Soto C (2009a) Are amyloids infectious? In: Maccioni RB, Perry G (eds) Current hypotheses and research milestones in Alzheimer's disease. Springer, New York, pp 171-180
65. Morales R, Green KM, Soto C (2009b) Cross currents in protein misfolding disorders: interactions and therapy. CNS Neurol Disord Drug Targets 8:363-371
66. Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 30:4528-4535
67. Novitskaya V, Bocharova OV, Bronstein I, Baskakov IV (2006) Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem 281:13828-13836
68. O'Donovan CN, Tobin D, Cotter TG (2001) Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem 276:43516-43523
69. O'Nuallain B, Williams AD, Westermark P, Wetzel R (2004) Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279:17490-17499
70. Paquet C, Privat N, Kaci R, Polivka M, Dupont O, Haik S, Laplanche JL, Hauw JJ, Gray F (2008) Cerebral amyloid angiopathy with co-localization of prion protein and b-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 116:567-573
71. Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, Requena JR (2006) Isolation and Characterization of a Proteinase K-Sensitive PrP Sc Fraction. Biochemistry 45:15710-15717
72. Piccardo P, Manson JC, King D, Ghetti B, Barron RM (2007) Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci USA 104:4712-4717
73. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383
74. Prusiner SB (2004) Early evidence that a protease-resistant protein is an active component of the infectious prion. Cell 116:S109-S111
75. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP Sc molecules with different conformations. Nat Med 4:1157-1165
76. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, Serban A, Vey M, Baron H, Giles K et al (2005) Diagnosis of human prion disease. Proc Natl Acad Sci USA 102:3501-3506
77. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J (2009) ER stress in Alzheimer's disease: A novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation 6:41
78. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-b protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842
79. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B (2005) The most infectious prion protein particles. Nature 437:257-261
80. Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, Schätzl H, Lasmézas CI (2007) In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 3:e125
81. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, Williamson RA (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:1514-1516
82. Solomon IH, Huettner JE, Harris DA (2010) Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells. J Biol Chem 285:26719-26726
83. Soto C (2001) Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498:204-207
84. Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4:49-60
85. Soto C, Castilla J (2004) The controversial protein-only hypothesis of prion propagation. Nat Med 10:S63-S67
86. Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65:184-189
87. Soto C, Satani N (2011) The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 17:14-24
88. Soto C, Estrada L, Castilla J (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 31:150-155
89. Srinivasan R, Marchant RE, Zagorski MG (2004) ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures. Amyloid 11:10-13
90. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB (1993) Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32:1991-2002
91. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le DA, Laude H, Beringue V (2010) The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 6:e1000859
92. Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JX, Masliah E (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 3:e3135
93. Tsuchiya K, Yagishita S, Ikeda K, Sano M, Taki K, Hashimoto K, Watabiki S, Mizusawa H (2004) Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD. Neuropathology 24:46-55
94. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A (2002) Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41:12868-12875
95. Walsh DM, Selkoe DJ (2007) A b oligomers-a decade of discovery. J Neurochem 101:1172-1184
96. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB (1999) Amyloid b-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274:25945-25952
97. Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, Selkoe DJ (2005) The role of cell-derived oligomers of A b in Alzheimer's disease and avenues for therapeutic intervention. Biochem Soc Trans 33:1087-1090
98. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL (2002) Soluble oligomers of b amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133-140
99. Westergard L, Christensen HM, Harris DA (2007) The cellular prion protein (PrP C ): its physiological function and role in disease. Biochim Biophys Acta 1772:629-644
100. Yan J, Fu X, Ge F, Zhang B, Yao J, Zhang H, Qian J, Tomozawa H, Naiki H, Sawashita J, Mori M, Higuchi K (2007) Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. Am J Pathol 171:172-180